IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,041,510 | +15.6% | 21,854 | +5.1% | 0.00% | 0.0% |
| Q1 2024 | $900,986 | -13.8% | 20,784 | +0.5% | 0.00% | 0.0% |
| Q4 2023 | $1,045,771 | +28.9% | 20,672 | +15.6% | 0.00% | 0.0% |
| Q3 2023 | $811,400 | +13.8% | 17,888 | +3.0% | 0.00% | 0.0% |
| Q2 2023 | $712,860 | +305848.5% | 17,374 | +166.4% | 0.00% | +100.0% |
| Q1 2023 | $233 | -64.9% | 6,521 | -62.8% | 0.00% | -50.0% |
| Q4 2022 | $663 | -99.8% | 17,542 | +145.7% | 0.00% | +100.0% |
| Q3 2022 | $316,000 | +49.1% | 7,141 | +116.6% | 0.00% | -66.7% |
| Q2 2019 | $212,000 | -19.1% | 3,297 | +2.0% | 0.00% | -25.0% |
| Q1 2019 | $262,000 | -15.2% | 3,233 | -43.4% | 0.00% | -33.3% |
| Q4 2018 | $309,000 | – | 5,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |